RESEARCH · GHK-CU 50MG · STRUCTURE-ACTIVITY
GHK-Cu Analogues and Derivatives: What Modifying Gly-His-Lys Has Taught Researchers About Copper Binding, Stability and Delivery
GHK-Cu is the copper(II) complex of a three-residue peptide, glycyl-L-histidyl-L-lysine. Because the molecule is so small, chemists have been able to change it one residue at a time, swap in non-natural amino acids, alter its backbone and attach it to larger carriers. Those modified versions are useful to a research laboratory for two reasons: they show which parts of the tripeptide matter for copper binding and for the effects measured in cell assays, and they define what the unmodified GHK-Cu used as a reference compound is, and is not. A 2014 review grouped the synthetic routes used for GHK and its modifications, from classical solution chemistry to solid-phase peptide synthesis with different protecting-group strategies [1]. This article summarises what the structure-activity work has found, and where it stops.
The starting point: how GHK holds copper
Solution studies from the early 1980s showed that copper(II) and GHK form several species whose distribution depends on pH, including ternary complexes when another amino acid such as histidine is present [2]. Later X-ray and spectroscopic work found that the complex is dimeric in the solid state but monomeric in solution, with copper bound by three nitrogen atoms: the N-terminal amine, a deprotonated amide nitrogen and the histidine imidazole. The fourth equatorial position is taken by a labile oxygen donor, and copper exchanged quickly between GHK molecules, which the authors attributed to a bis-GHK species [3].
The same study compared GHK with DAHK, the copper-binding N-terminus of serum albumin. Copper in the DAHK complex exchanged very slowly, and only the GHK complex could be reduced to copper(I) with release of the metal under the conditions tested [3]. A broader review describes these N-terminal Xxx-His and Xxx-Zzz-His motifs as a general way to add a high-affinity copper(II) site to almost any peptide or protein [4]. In other words, GHK is one member of a family of copper-binding sequences, and its particular behaviour comes from its exact arrangement of donor atoms.
Swapping the histidine
A central question is whether the histidine is essential. Conato and colleagues replaced it with two synthetic, conformationally constrained amino acids, L-spinacine and L-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (Tic), and characterised the copper complexes by potentiometry, calorimetry, UV-visible, circular dichroism and EPR spectroscopy [5]. All three ligands formed complexes of different stoichiometry and stability, with evidence of binuclear species. In growth assays both analogues showed activity comparable to or higher than GHK, and none of the three peptides was significantly degraded in human serum over at least three hours [5].
The authors drew a structure-activity conclusion that is often overlooked: copper complex formation, driven by the first residue (glycine), appeared necessary; the second residue did not appear to play a specific role; and a free side chain on the third residue, lysine, appeared to be of fundamental importance. At physiological pH, they proposed, the lysine amino group is protonated and not involved in copper binding, leaving it available for interactions with cellular targets [5]. A follow-up study with nickel(II) and the same analogues likewise found no involvement of the lysine side-chain amine in metal coordination [6].
A different histidine swap explored antioxidant chemistry. Replacing histidine with 2-thiohistidine, the amino acid related to ergothioneine, gave a GHK analogue that completely quenched hydroxyl and ABTS radicals in the authors’ assays, with antioxidant capacity greater than expected from free 2-thiohistidine alone [7]. Related work on unmodified GHK showed that it forms adducts with the lipid-derived aldehyde 4-hydroxynonenal, but less potently than carnosine, which the authors linked to the folded, hydrogen-bonded conformation of GHK in solution [8].
Changing the first residue: AHK-Cu and GGH
Replacing glycine with alanine gives AHK, and its copper complex has been studied separately. In one study, AHK-Cu stimulated elongation of human hair follicles ex vivo and proliferation of cultured dermal papilla cells, raised the Bcl-2/Bax ratio and reduced cleaved caspase-3 and PARP in those cells [9]. Gly-Gly-His (GGH), which places histidine third rather than second, has also been compared directly with GHK: in normal human dermal fibroblasts, GGH, GHK, copper chloride and their copper complexes all decreased TNF-alpha-dependent IL-6 secretion [10]. The fact that copper chloride alone had an effect in that assay is a reminder that free copper is a necessary control whenever a copper peptide is tested.
Protecting the backbone
Short natural peptides are vulnerable to proteases. One early strategy reversed a single amide bond: in a partially retro-inverso analogue, the bond between histidine and lysine was rewritten from -CONH- to -NHCO-, a change not expected to disturb the spatial arrangement of the side chains. In human plasma in vitro, the analogue was roughly ten times more stable than the parent peptide [11]. Stability in plasma does not tell you how a molecule behaves in culture medium or in a buffer on the bench, but the result shows that GHK’s susceptibility to degradation can be engineered.
Conjugates: biotin, oligoarginine, fatty acids and hyaluronan
Many derivatives attach GHK to something larger. Biotinylated GHK bound a collagen matrix and red-cell membranes more effectively than a Boc-protected GHK, and a collagen film carrying it was studied in a rat dermal wound model, where copper concentration at the wound site rose about ninefold [12]. A newer biotin-GHK conjugate still coordinated copper(II) and was characterised in ascorbate-oxidation, antiglycation, streptavidin-binding and amyloid-beta aggregation assays in vitro [13].
Adding four arginines to make the heptapeptide GHK-R4 accelerated cellular penetration and increased collagen synthesis in vitro relative to GHK, although the authors noted that the arginine tail has cell-penetrating and matrix-metalloproteinase-inhibitory activity of its own [14]. Fatty-acid conjugates of GHK, some with altered sequences, were screened for antimicrobial activity, with minimum inhibitory concentrations in the range of tens to hundreds of micrograms per millilitre depending on compound and organism [15]. More recently, GHK grafted onto hyaluronic acid at different loadings bound copper(II) and was studied for antioxidant activity and for the release of BDNF, VEGF and BMP-2 in cell assays [16].
What the derivative literature does not settle
- Comparability. Each analogue was tested in its own assay system by its own group. Few studies compared several derivatives side by side under identical conditions, so ranking them from the published record is not possible.
- Carrier effects. With conjugates, part of the measured activity may come from the carrier (collagen, oligoarginine, hyaluronan) rather than from GHK, as the oligoarginine study itself notes [14].
- Species and model. Results span solution chemistry, bacterial assays, cultured cells and rodent wounds. None of these is a claim about any outcome in people.
- The reference compound. This body of work describes modified molecules. It defines unmodified GHK-Cu by contrast; it is not evidence about a particular commercial GHK-Cu preparation.
Why this matters when you source GHK-Cu
If your protocol specifies GHK-Cu, these studies explain what you are and are not ordering. “Copper peptide” is used loosely in marketing for GHK-Cu, AHK-Cu, GGH-Cu and various conjugates, which are chemically distinct and were studied in different systems. When you order, confirm the exact sequence and that the material is the unmodified tripeptide copper complex rather than a derivative, and ask for identity data (for example mass spectrometry) and the copper-to-peptide relationship for your batch. A short checklist for sourcing GHK-Cu in Canada is covered in our supplier checklist for GHK-Cu; the chemistry of the complex itself is covered in our overview of copper coordination and speciation.
GHK-Cu 50mg at PurixLab
GHK-Cu 50mg: research-grade glycyl-L-histidyl-L-lysine copper complex, C$49 per vial (CAD, before tax), supplied for laboratory research only. It is the unmodified tripeptide copper complex, not one of the analogues or conjugates described above, and it is not the specific material used in any of the studies cited. The product page does not currently display a certificate of analysis; if your project needs particular supporting documentation, email [email protected] before ordering and tell us what you need. Product page: purixlab.com/product/ghk-cu-50mg/.
PurixLab ships within Canada only, from stock held in Toronto. Standard shipping is C$15, and shipping is free when the product subtotal is C$200 or more after discounts. Orders outside the GTA ship by Canada Post Xpresspost. Prices are in CAD and taxes are calculated from your shipping address at checkout.
In Toronto and the GTA, our own team delivers orders the same day or the next day. There is no fixed GTA delivery fee: after you place your order, we email you to confirm the delivery time and any delivery charge. There is no storefront or local pickup.
Payment is by Interac e-Transfer (instructions are shown at checkout). Current offers are shown on the product page and in your cart; offers do not stack.
For laboratory research use only. Not for human or veterinary use, not for consumption, injection or application to skin, and purchasers must be 18 or older. The studies summarised above describe specific materials in published research; they are not claims about any PurixLab product.
Questions: [email protected] · Shipping & Delivery · Toronto & GTA delivery · PurixLab FAQ
References
- Kukowska M, Dzierzbicka K. Developments in the synthesis and biological activity of glycyl-L-histydyl- L-lysine derivatives. Curr Med Chem. 2014;21(13):1505-21. PubMed 24350846 · doi:10.2174/0929867321666131218095056
- Lau SJ, Sarkar B. The interaction of copper(II) and glycyl-L-histidyl-L-lysine, a growth-modulating tripeptide from plasma. Biochem J. 1981;199(3):649-56. PubMed 7340824 · PMC1163421 · doi:10.1042/bj1990649
- Hureau C, Eury H, Guillot R, et al. X-ray and solution structures of Cu(II) GHK and Cu(II) DAHK complexes: influence on their redox properties. Chemistry. 2011;17(36):10151-60. PubMed 21780203 · doi:10.1002/chem.201100751
- Gonzalez P, Bossak K, Stefaniak E, et al. N-Terminal Cu-Binding Motifs (Xxx-Zzz-His, Xxx-His) and Their Derivatives: Chemistry, Biology and Medicinal Applications. Chemistry. 2018;24(32):8029-8041. PubMed 29336493 · PMC6152890 · doi:10.1002/chem.201705398
- Conato C, Gavioli R, Guerrini R, et al. Copper complexes of glycyl-histidyl-lysine and two of its synthetic analogues: chemical behaviour and biological activity. Biochim Biophys Acta. 2001;1526(2):199-210. PubMed 11325542 · doi:10.1016/s0304-4165(01)00127-1
- Conato C, Kozłowski H, Swiatek-Kozłowska J, et al. Formation equilibria of nickel complexes with glycyl-histidyl-lysine and two synthetic analogues. J Inorg Biochem. 2004;98(1):153-60. PubMed 14659644 · doi:10.1016/j.jinorgbio.2003.09.010
- Jenny KA, Ruggles EL, Liptak MD, et al. Ergothioneine in a peptide: Substitution of histidine with 2-thiohistidine in bioactive peptides. J Pept Sci. 2021;27(10):e3339. PubMed 34008255 · PMC8443123 · doi:10.1002/psc.3339
- Beretta G, Artali R, Regazzoni L, et al. Glycyl-histidyl-lysine (GHK) is a quencher of alpha,beta-4-hydroxy-trans-2-nonenal: a comparison with carnosine. insights into the mechanism of reaction by electrospray ionization mass spectrometry, 1H NMR, and computational techniques. Chem Res Toxicol. 2007;20(9):1309-14. PubMed 17672515 · doi:10.1021/tx700185s
- Pyo HK, Yoo HG, Won CH, et al. The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res. 2007;30(7):834-9. PubMed 17703734 · doi:10.1007/BF02978833
- Gruchlik A, Jurzak M, Chodurek E, Dzierzewicz Z. Effect of Gly-Gly-His, Gly-His-Lys and their copper complexes on TNF-alpha-dependent IL-6 secretion in normal human dermal fibroblasts. Acta Pol Pharm. 2012;69(6):1303-6. PubMed 23285694
- Dalpozzo A, Kanai K, Kereszturi G, Calabrese G. H-Gly-His psi (NHCO)Lys-OH, partially modified retro-inverso analogue of the growth factor glycyl-L-histidyl-L-lysine with enhanced enzymatic stability. Int J Pept Protein Res. 1993;41(6):561-6. PubMed 8349414 · doi:10.1111/j.1399-3011.1993.tb00478.x
- Arul V, Gopinath D, Gomathi K, Jayakumar R. Biotinylated GHK peptide incorporated collagenous matrix: A novel biomaterial for dermal wound healing in rats. J Biomed Mater Res B Appl Biomater. 2005;73(2):383-91. PubMed 15803494 · doi:10.1002/jbm.b.30246
- Tosto R, Vecchio G, Bellia F. New Biotinylated GHK and Related Copper(II) Complex: Antioxidant and Antiglycant Properties In Vitro against Neurodegenerative Disorders. Molecules. 2023;28(18):6724. PubMed 37764500 · PMC10538196 · doi:10.3390/molecules28186724
- Hur GH, Han SC, Ryu AR, et al. Effect of oligoarginine conjugation on the antiwrinkle activity and transdermal delivery of GHK peptide. J Pept Sci. 2020;26(2):e3234. PubMed 31788907 · doi:10.1002/psc.3234
- Kukowska M, Kukowska-Kaszuba M, Dzierzbicka K. In vitro studies of antimicrobial activity of Gly-His-Lys conjugates as potential and promising candidates for therapeutics in skin and tissue infections. Bioorg Med Chem Lett. 2015;25(3):542-6. PubMed 25556094 · doi:10.1016/j.bmcl.2014.12.029
- Greco V, Lanza V, Tomasello B, et al. Copper Complexes with New Glycyl-l-histidyl-l-lysine-Hyaluronan Conjugates Show Antioxidant Properties and Osteogenic and Angiogenic Synergistic Effects. Bioconjug Chem. 2025;36(4):662-675. PubMed 40123442 · doi:10.1021/acs.bioconjchem.4c00545